Atherosclerosis

Serious limitations noted of attempt to compare GLP-1 agonists, SGLT-2 inhibitors, however

If finerenone isn't available, try spironolactone, said researcher

Twin study suggests a difference in CVD impact from becoming obese despite "good genes"

Natural history study lays the groundwork for intervention trials

The technique was not linked to a reduction in postoperative pulmonary complications

Residual inflammation is important factor of cardiovascular risk

Effects observed in inflammation and improved clinical outcomes

But are proposed limits for particulate matter pollution enough?

Twin study suggests special monitoring in some individuals

Not on the basis of increased dietary saturated fat, the Skeptical Cardiologist finds

ASCVD risk prediction may have been led astray all along

LDL cholesterol reductions with cinnamon, garlic, and others not on par with statin

Comparisons against contemporary medical therapy are still lacking

Antiplatelet strategy has good results in longer follow-up of SMART-CHOICE trial